Monday, October 6, 2025

Latest

Mind Medicine To Raise Further $19.5 Million In Bought Deal

Mind Medicine (NEO: MMED) this morning announced that it is conducting yet another round of financing, after having raised $92.1 million just two months ago. The latest round of financing will take the form of a bought deal, lead by Canaccord Genuity, with funds largely said to come from one large institutional investor.

The financing will see Mind Medicine sell a total of 6.0 million units of the company at a price of $3.25 each, for gross proceeds of $19.5 million. Each unit is to contain one subordinate voting share and one half of a subordinate voting share warrant. Each warrant is valid for a period of three years from the date of issuance, and contains an exercise price of $4.40 per share.

Warrants issued under the offering are also subject to an acceleration clause, whereby the company can force the early expiry of the warrants in the event that the firms equity trades above $6.90 for a period of five consecutive trading days on a volume weighted basis.

The offering is currently slated to close March 9, 2021.

Proceeds from the financing will be used for the firms experiential LSD program, its LSD microdosing program, and Project Albert, the firms mental health tech platform, and general working capital purposes.

Mind Medicine last traded at $3.64 on the Neo Exchange.


Information for this briefing was found via Sedar and MindMed. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Fortune Bay: The Potential Billion Dollar Project

Japan Gold Enters New Chapter as Barrick Alliance Concludes – John Proust

Barrick Mining’s “Company Defining [Gold] Discovery”

Recommended

Nord Precious Metals Produces High Grade Silver Concentrate From Tailings

ESGold Secures $9 Million In Non-Dilutive Funding From Ocean Partners

Related News

MindMed Sees Positive Results For Its LSD Treatment For Anxiety Disorders Published In Peer-Reviewed Journal

Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced on Thursday that the...

Thursday, September 8, 2022, 05:03:00 PM

Mindmed To Conduct 15-To-1 Reverse Split To Meet Nasdaq Listing Requirements

In a classic Canadian small cap move, Mind Medicine (NEO: MMED) last night announced that...

Friday, August 5, 2022, 08:42:02 AM

MindMed Acquires HealthMode For $41.6 Million

MindMed (NEO: MMED) this morning announced that it will be acquiring that of HealthMode in...

Thursday, February 18, 2021, 08:21:32 AM

MindMed Starts Dosing Patients In Phase 1 Clinical Study On MDMA-Like Substances

Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced on Tuesday that the...

Wednesday, September 21, 2022, 11:23:00 AM

JR Rahn: Using LSD To Treat Mental Health – The Daily Dive

For our Saturday edition of The Daily Dive, host Cassandra Leah sits down with that...

Saturday, March 20, 2021, 01:30:00 PM